B.C. Stem Cell Cancer Advances | UBC Breakthrough | AcademicJobs.ca
Explore UBC's groundbreaking stem cell research producing helper T cells for scalable cancer therapies, enhancing CAR-T efficacy and accessibility in Canada.
No reviews yet. Be the first to rate Megan!
Megan Levings is a Professor in the Department of Surgery at the Faculty of Medicine and in the School of Biomedical Engineering at the Faculty of Applied Science and Faculty of Medicine at the University of British Columbia. She serves as Head of Immunity in Health and Disease at the BC Children’s Hospital Research Institute and as Director of the Childhood Diseases Research Theme at the same institute. Her research program centers on immune cells known as T regulatory cells and their role in immune tolerance, with the goal of developing cell-based therapies to treat immune-mediated diseases including transplant rejection and autoimmunity.
Dr. Levings leads efforts to understand the molecular and cellular biology of T regulatory cells, to advance first-in-human clinical trials of regulatory T cell therapies in transplantation, and to implement standardized immune monitoring in clinical settings. She has received the Canadian Society for Immunology Investigator Award and the YWCA Woman of Distinction Award in Science, Research & Technology. She currently chairs the Federation of Clinical Immunology Societies Centers of Excellence. Her laboratory integrates laboratory and clinical studies to translate findings into therapeutic applications for chronic immune-mediated conditions.
Explore UBC's groundbreaking stem cell research producing helper T cells for scalable cancer therapies, enhancing CAR-T efficacy and accessibility in Canada.